New York Assembly Bill A07912

New York 2025-2026 Regular Session

• Introduced: 4/11/25
• Refer: 4/11/25
• Report Pass: 5/6/25
• Refer: 5/6/25
• Report Pass: 5/28/25
• Refer: 5/28/25
• Refer: 1/7/26

Caption

Prohibits the sale of children's products, mattresses and upholstered furniture containing fiberglass unless they contain a prominent label; defines children's product; prohibits custom upholsterers from repairing or restoring any children's product, mattress or furniture with parts that contain fiberglass; provides remedies for violations.

Impact

If enacted, A07912 would have significant implications for manufacturers and retailers of children's items, mattresses, and upholstered furniture in New York. By imposing mandatory labeling, the bill aims to raise awareness regarding the risks associated with fiberglass, particularly for vulnerable populations like children. Additionally, custom upholsterers would be prohibited from using fiberglass components in the restoration of such items, which may lead to changes in industry practices and the availability of materials used for repairs.

Summary

Bill A07912 seeks to amend New York's general business law to prohibit the sale of certain children's products, mattresses, and upholstered furniture that contain fiberglass unless these items carry a prominent label warning consumers about the potential hazards. This legislation emphasizes the protection of children from exposure to materials that can be harmful if ingested, inhaled, or come into contact with skin. The bill clearly defines what constitutes a 'children's product' and outlines the labeling requirements that manufacturers must follow to ensure compliance.

Contention

Notably, the bill's introduction and expected passage may face opposition from industry stakeholders concerned about cost implications and the feasibility of compliance. Some may argue that the labeling requirements could result in increased prices for consumers and challenge business operations. Furthermore, there may be discussions on whether existing labels are sufficient or if additional warnings are necessary, thus raising points of contention around regulatory burdens versus consumer safety.